NCT01891058View on ClinicalTrials.gov

Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

NACompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

July 18, 2013

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DEVICE

drug-shock vs shock only

procainamide followed by electrocardioversion if necessary vs cardioversion only.

Trial Locations (10)

2TN 1M7

Foothills Medical Centre, Calgary

Unknown

Rockyview General Hospital, Calgary

Hopital Du Sacre-Coeur, Montreal

Hopital de L'Enfant-Jesus, Québec

T6G 2B7

University of Alberta Hospital, Edmonton

V5Z 1M9

Vancouver General Hospital, Vancouver

K7L 2V7

Kingston General Hospital, Kingston

K1Y 4E9

Ottawa Hospital Research Institute, Ottawa

M5G 1X5

Mount Sinai Hospital, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

Sponsors
All Listed Sponsors
collaborator

The Ottawa Hospital

OTHER

lead

Ottawa Hospital Research Institute

OTHER

NCT01891058 - Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED | Biotech Hunter | Biotech Hunter